$NuCana (NCNA.US)$ NEWS NuCana Presents Data at the AACR 202...
NEWS
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
NuCana plc (NASDAQ: NCNA) presented two posters at the AACR Annual Meeting showcasing the effects of NUC-7738 on cancer cell lipid metabolism and ribosome biogenesis. NUC-7738 was found to reprogram lipid metabolism in tumors, making them less aggressive and promoting cancer cell death. The drug alters genes critical for cancer growth and survival, potentially offering a novel approach to inhibit ribosome biogenesis in cancer cells.
NuCana plc (NASDAQ: NCNA) presented two posters at the AACR Annual Meeting showcasing the effects of NUC-7738 on cancer cell lipid metabolism and ribosome biogenesis. NUC-7738 was found to reprogram lipid metabolism in tumors, making them less aggressive and promoting cancer cell death. The drug alters genes critical for cancer growth and survival, potentially offering a novel approach to inhibit ribosome biogenesis in cancer cells.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
456Followers
66Following
2907Visitors
Follow